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Objective: Minimally invasive methods (MIMs) are now available for the management of visceral artery aneurysms and
pseudoaneurysms (visceral artery aneurysms [VAA]). The purpose of this study was to review our 10-year experience with
the MIM of treating VAA.
Methods: All patients evaluated from June 1999 to June 2009 with VAAs were reviewed. Demographics, therapy, and
results were analyzed.
Results: MIM was attempted in 185 aneurysms in 176 patients. Initial intervention was successful in 98% of aneurysms.
Sixty-three (34%) aneurysms were located in the splenic artery, 56 (30%) in the hepatic, 28 (15%) in the gastroduodenal,
16 (8.6%) in the pancreaticoduodenal, six (3.2%) in the superior mesenteric, four (2.1%) in the gastric, four (2.1%) in the
celiac, four (2.1%) in the gastroepiploic, two (1%) in the inferior mesenteric, and one (0.5%) in the middle colic artery.
Pseudoaneurysms were more common than true aneurysms (64% vs 36%). Bleeding was the indication for intervention in
86 aneurysms (46%). Initial treatment was successful in 177 aneurysms (98%). Reintervention was required in five (3%)
aneurysms within 30 days. Coiling was used alone in 139 aneurysms (75%) and in combination with at least one other
technique in 20 (11%) cases. Thirty-day aneurysm-related mortality was 3.4% (six deaths). Five additional deaths
occurred during 30-day follow-up, although none was related to complications of the aneurysms (2.8%).
Conclusions:MIM for visceral artery aneurysms can be used alone or in combination to effectively treat VAAs in elective


























rThe more prevalent use and accuracy of enhanced
imaging techniques such as computed tomography and
ultrasonography have increased the frequency of diagnosis
of aneurysmal degeneration of the visceral arteries. Both
true aneurysms (TVA) and pseudoaneurysms (VAP) have
become a more frequent vascular finding.1 The develop-
ment of VAPs may be related to a concomitant increase in
percutaneous and endoluminal biliary interventions.2 Re-
gardless of etiology, visceral artery aneurysms (VAAs), both
true and pseudoaneurysms, are still rare entities, with inci-
dence in autopsy and angiographic series of 0.01% to 2%.3-5
VAAs may affect any of the branches of the abdominal
aorta, although hepatic and splenic aneurysms account for
80% of those reported.6
Traditional management strategies for VAAs have in-
cluded serial surveillance or surgical intervention. Classic
surgical options included aneurysm ligation with or with-
out end-organ resection (ie, splenectomy) and aneurysmal
resection with revascularization.7 With the development of
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966inimally invasive interventional therapies, the manage-
ent options for patients with VAAs have been expanded.
number of endovascular and percutaneous transabdom-
nal techniques are now available and have been described
y many authors in the published literature. However,
here are limited large reviews of outcomes with these
echniques in multiple arterial sites with long-term follow-
p. We thus reviewed our experience with the minimally
nvasive treatment of visceral artery aneurysms and pseu-
oaneurysms.
ETHODS
After institutional review board approval, a retrospec-
ive review of patients diagnosed with aneurysms or pseu-
oaneurysms of the celiac, superior mesenteric, inferior
esenteric arteries, or their branches at The Mayo Clinic
rom June 1999 to June 2009 was conducted. This in-
luded patients in three distinct geographies: Rochester,
inn, Jacksonville, Fla, and Phoenix, Ariz. Patients diag-
osed but not undergoing treatment or those managed
ith open surgical techniques were specifically excluded.
atient demographic information and common risk factors
or vascular disease were recorded.
Aneurysm location and presenting symptoms were re-
iewed. The indication for intervention and means of inter-
ention were determined by the individual managing phy-
ician. In general, any degree of bleeding was considered an
ndication for intervention. Presence of symptoms, aneu-
ysm size, and bleeding were considered when determining
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niques.
The records were reviewed for overall 30-daymortality,
aneurysm-related 30-daymortality, morbidity, and cause of
death. Aneurysm-related mortality was defined as that
which was directly related to aneurysm rupture or bleeding,
or from complications related to intervention. All records
were reviewed for determination of success of intervention.
Additionally, a simple three-question survey was sent to all
patients. This survey inquired as to any recurrence of the
aneurysm, any subsequent treatment of the aneurysm, and
any complications from the intervention on the aneurysm.
RESULTS
During the study period, a total of 185 aneurysms in
176 patients were identified. All patients underwent mini-
mally invasive intervention for the management of a VAA.
There were 99 men (56%) and 77 women (44%) with ages
ranging from 18 to 89 years (mean, 58 years). The aneu-
rysms treated are listed in Table I. Fifteen aneurysms (8%)
could be attributed to underlying disease states including
Ehlers-Danlos syndrome, fibromuscular dysplasia, and pol-
yarteritis nodosum.
In 38 patients, the aneurysms could be directly tied to
previous intervention. Fourteen patients had prior liver
transplants, 13 underwent Whipple procedures, six under-
went resection of cholangiocarcinoma, three underwent
biliary reconstruction after complications from cholecystec-
tomies, and two underwent percutaneous liver biopsies.
These procedures were taken into account when diagnos-
ing the aneurysms as pseudoaneurysms. Trauma accounted
for another 11 pseudoaneurysms, four of which were
treated for acute bleeding.
Pseudoaneurysms comprised 64% (119) of all aneu-
rysms. The proportion of pseudoaneurysms versus true
aneurysms differed by arterial location (Table I). The diag-
nosis of true aneurysms versus pseudoaneurysms was left to
the discretion of the providers. When discrepancies arose in
the medical records regarding the accurate diagnosis, the
records were reviewed by the authors and a determination
was made.
Aneurysm size was the most common primary indica-







Splenic artery 40 (63%) 23 (37%)
Hepatic artery 11 (20%) 45 (80%)
Gastroduodenal artery 3 (11%) 25 (89%)
Pancreaticoduodenal artery 5 (31%) 11 (69%)
Superior mesenteric artery 2 (33%) 4 (67%)
Gastric artery 1 (25%) 3 (75%)
Celiac artery 0 (0%) 4 (100%)
Gastroepiploic artery 2 (50%) 2 (50%)
Inferior mesenteric artery 1 (50%) 1 (50%)
Middle colic artery 0 (0%) 1 (100%)tion for intervention. This was the primary reason for wntervention in 99 aneurysms (53%; Table II). Patients
resenting with pain related to aneurysm size comprised
5% of nonbleeding aneurysms. Pain was attributed to the
neurysm only if the provider felt that its size and anatomic
ocation could explain the pain described by the patient.
leeding was the indication for intervention in 62 (33%)
neurysms, while aneurysm rupture occurred in 24 (13%)
ases.
Aneurysm size was a more common indication for
ntervention in true aneurysms. Fifty-four true aneurysms
82%) required intervention due to concerns regarding
ize, whereas only 12 true aneurysms (18%) required inter-
ention for control of bleeding. Seventy-five (63%) pseu-
oaneurysms required intervention due to bleeding, but
nly 44 (37%) had intervention secondary to concerns
egarding size.
Endovascular techniques utilized included coiling, cov-
red stent exclusion, thrombin injection, Gelfoam (Pfizer
nc, New York, NY) injection, gluing, plug deployment,
article injection, and polyvinyl alcohol injection. Transab-
ominal coiling and thrombin injection under ultrasound
r fluoroscopic guidance was also employed.
The femoral artery was utilized for access in 148 pa-
ients, while the brachial artery was used in 28 patients.
ccess-site complications including prolonged pain and
ematoma were noted in 12 (6.8%) patients. No access-site
omplication required reintervention.
Endovascular coiling was the sole interventional tech-
ique employed in 144 (78%) of cases (Table III). Coiling
able II. Indication for intervention by location
neurysm location Bleeding Size
plenic artery 17 (27%) 46 (73%)
epatic artery 31 (55%) 25 (45%)
astroduodenal artery 21 (75%) 7 (25%)
ancreaticoduodenal artery 7 (44%) 9 (66%)
uperior mesenteric artery 2 (33%) 4 (67%)
astric artery 3 (75%) 1 (25%)
eliac artery 1 (25%) 3 (75%)
astroepiploic artery 3 (75%) 1 (25%)
nferior mesenteric artery 0 (0%) 2 (100%)
iddle colic artery 1 (100%) 0 (0%)
able III. Techniques employed in aneurysm treatment
echnique Number of aneurysms treated
oilinga 162




olyvinyl alcohol injection 2
luing 1
ndoluminal thrombin injection 1
ercutaneous coiling 2
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April 2011968 Fankhauser et alrysms (1%), Gelfoam injection in three (2%), particle injec-
tion in seven (4%), gluing in two (1%), and polyvinyl
alcohol injection in one aneurysm (1%). Coiling was per-
formed in a transabdominal approach in two cases (1%).
Coiling was combined with two additional techniques in-
cluding stenting or thrombin, particle, or gelfoam injection
in four cases (2%). Covered stent placement was used as the
sole technique in 10 aneurysms (5%).
Initial treatment was successful in 182 (98%) aneu-
rysms. Initial success is defined as stopping the flow within
the aneurysm or successfully excluding it by the end of the
procedure. Four aneurysms could not be successfully
treated endovascularly or transabdominally and were man-
aged with serial imaging. None has required intervention or
suffered complication.
During repeat imaging within the first 30 days, persis-
tent aneurysm flow was seen in five (3%) aneurysms, and
subsequent reintervention was undertaken. Follow-up in-
tervention was carried out with minimally invasive tech-
niques and was successful in all five cases.
There were 11 deaths in the initial 30-day period leading
to an overall 30-day mortality rate of 6.2%. Aneurysm-
related 30-day mortality rate was 3.4%. This was comprised
of six cases of death due to bleeding. Two deaths occurred
from persistent or recurrent bleeding, while the families of
four patients withdrew care before further intervention was
attempted. Five deaths (2.8%) occurred in patients within
the first 30 days that were not directly related to their
aneurysms.
Twenty-one patients were lost to follow-up within the
first 30 days. Repeat imaging within the first 30 days is
available on 150 patients (85%). Long-term follow-up for
these patients was 524 days (range, 7-3808 days). The
length of follow-up was measured from the time of inter-
vention to the most recent clinical note for the patient
within our institutional records or the date of the return of
the survey, whichever was longer. There were 10 additional
known deaths discovered during long-term follow-up
(30 days), none of which were aneurysm-related. These
deaths were tabulated by reviewing medical records at our
institution and from the survey results.
The follow-up survey was sent to 150 patients and was
returned by 57 patients (38%) at an average of 1,306 days
posttreatment. Combined medical record review with sur-
vey results revealed only one patient with a long-term
recurrence. This patient reported bleeding from a recurrent
splenic artery aneurysm and was managed at another facility
by minimally invasive techniques.
Follow-up was available for nine of the 10 aneurysms
treated with covered stents, while one of these patients was
lost to follow-up within the first 30 days. The average
follow-up for these nine patients was 386 days (range,
9-1502 days). There was no evidence of in-stent thrombo-
sis.
Major short-term morbidity was defined as that which
required additional intervention within the first 30 days.
There were no cases in this series aside from the cases of
recurrent or persistent symptoms. Minor morbidity in- mluded access-site hematoma or pain, persistent abdominal
ain, or access-site cellulitis or infection. There were 12
ases (6.8%) of access-site hematoma, six cases (3.4%) of
ersistent abdominal pain, and one case (0.5%) of cellulitis
t the femoral access site. There was also one minor injec-
ion site reaction to local anesthetic that was self-limited.
Partial liver infarct was noted in eight cases after hepatic
rtery aneurysm treatment. Four intraparenchymal hepatic
rtery aneurysms were treated without infarct. Partial or
omplete splenic infarct was noted after 17 cases of splenic
rtery aneurysm treatment. Three intraparenchymal splenic
rtery aneurysms were treated without infarct. None of
hese infarcts caused clinically significant complications
ithin the first 30 days.
Two patients (1.1%) reported long-term complications
elated to treatment of their aneurysms and sought addi-
ional care at our institution. One patient had bile duct
schemia related to gastroduodenal artery aneurysm coiling
hat required hepaticojejunostomy. Another patient devel-
ped sepsis following splenic infarction managed by emer-
ent splenectomy as a result of coiling of a splenic artery
neurysm.
ISCUSSION
The diagnosis of VAA has increased with the increased
se of enhanced imaging techniques and evolving trends in
iliary intervention, organ transplantation, and trauma
anagement.8,9 Concomitantly, the number of minimally
nvasive techniques available to treat these aneurysms has
xpanded. This series represents an experience from man-
gement of aneurysms and pseudoaneurysms in multiple
rterial beds of varying etiologies. The techniques used in
reating them are just as varied.
VAAs comprise a heterogenous group as they occur in
aried arterial locations and stem from varied etiologies.
herefore, the natural history and behavior of these aneu-
ysms is difficult to characterize on a global scale. Regard-
ess of etiology, VAAs carry a definite risk of rupture,
lthough that risk varies with aneurysm size and location.10
he indication for intervention has traditionally been re-
ated to concerns over the risk of rupture due to the high
ssociated mortality with rupture. In general, pseudoaneu-
ysms are more likely to rupture than true aneurysms, and
ome have proposed managing all pseudoaneurysms with
ntervention.10,11 Aneurysms of the splenic artery are the
ost commonly encountered and least likely to rupture
xcept during pregnancy.12 Maternal and fetal mortality in
he setting of rupture exceeds 75%.13 Aneurysms of the
xtraparenchymal hepatic arteries also hold high rates of
upture and merit intervention at the time of diagnosis.14
neurysms of other visceral arteries are less common and
ess well-studied, but it is generally accepted that all symp-
omatic aneurysms and those diagnosed in women of child-
earing age merit intervention.15
With the advent of endovascular and percutaneous
ptions for management, the indications for treatment are
hifting. When open surgery was the only available treat-
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bearing age, and asymptomatic aneurysms over 2 cm in size
in good-risk surgical candidates.15 Now that less invasive
methods are available, the indications for intervention have
broadened. We currently treat most pseudoaneurysms
when diagnosed and all aneurysms with any degree of
bleeding. Historical size criteria for intervention in aneu-
rysms are still referenced, but the overall trend has been
toward earlier intervention instead of serial surveillance.
Less often do we, the authors, wait until an aneurysm
reaches this historic threshold for intervention. Our treat-
ment options have now focused on minimally invasive
options as the first-line approach with open surgical inter-
vention for those patients with unsuitable anatomy. Truly
prohibitive anatomy is rarely encountered, and often inter-
vention is attempted even with extremely tortuous or nar-
row vessels. One contraindication to endovascular or trans-
abdominal intervention is the absolute need to maintain
patency in the feeding vessel, such as in a hepatic artery
feeding a failing liver. If patency is unlikely to be preserved
by these minimally invasive methods, then open surgical
intervention is considered.
The ultimate decision to intervene in the aneurysms in
our study was left to the individual provider and was not
based on pure size criteria. There was more variability in the
decision to intervene on true aneurysms than pseudoaneu-
rysms, and there was considerable variability between pro-
viders. Just as with the decision to intervene, the diagnosis
of a true versus a pseudoaneurysm was made by the provid-
ers caring for the patient, including the interventionalist
performing the procedure, the radiologist interpreting the
image, and the primary physicians caring for the patient.
The initial decision to pursue a minimally invasive interven-
tion is based on several factors, including interventionalist
experience, equipment availability, support staff training,
and anatomical considerations. If maintaining end-organ
blood flow is crucial and would likely be compromised by
an endovascular or percutaneous technique, then surgical
aneurysm resection with revascularization is necessary.
The treatment techniques used for each aneurysm was
individualized. Coil embolization was most frequently used
overall, especially in cases where preserving vessel patency
was not a priority. Several different options for coil embo-
lization are available, and their use is dependent upon
vascular and aneurysm anatomy. In two patients, we de-
ployed covered stents to further occlude feeding vessels
after coiling aneurysms. Intraparenchymal hepatic or
splenic aneurysms can be treated as well by coiling via
super-selective microcatheters. In this series, 12 intraparen-
chymal hepatic artery aneurysms and four intraparenchymal
splenic aneurysms were treated by coiling alone or coiling
and stenting.
In addition to coiling, aneurysm exclusion by covered
stent deployment was the most frequently utilized tech-
nique. Covered stents offer the benefit of maintaining
vessel patency and end-organ perfusion, but certain ana-
tomic considerations restrict their use. There must be suf-
ficient vessel length on either side of the aneurysm to ensure tgood seal, and severe tortuosity often precludes stent use.
he increasing availability of smaller and more flexible
tents has increased the number of aneurysms amenable to
tenting with covered stents. The risk of stent thrombosis
nd occlusion is still a real concern, and no consensus has
een reached regarding antiplatelet or antithrombotic
edication use poststenting. In our series, we did not see
ny cases of stent thrombosis in the 10 aneurysms that were
reated with a mean follow-up of 386 days. Rossii et al
eported four celiac and splenic artery aneurysms treated by
overed stent exclusion that saw no evidence of stenosis at
ollow-up of 16 to 24 months.16 Long-term follow-up is
till needed to assess the durability of these stents, although
he initial results are promising.
In our series, both endovascular and transabdominal
echniques were employed and often used together. Vascu-
ar tortuosity or sharp angulation may preclude endovascu-
ar treatment. In these cases, we found ultrasound-guided
ercutaneous aneurysm access to be an invaluable addi-
ional technique. This technique has succeeded in treating
ifficult-to-access aneurysms that otherwise would have
equired open surgical intervention. Two such aneurysms
n this series were pseudoaneurysms of the pancreaticodu-
denal artery. Once visualized angiographically, these an-
urysms were accessed percutaneously using ultrasound
nd fluoroscopic guidance. Both endoluminal and percuta-
eous angiography were used to verify positioning before
ercutaneous coil deployment. We used a similar technique
or percutaneous thrombin injection of three additional
neurysms of the hepatic, splenic, and inferior mesenteric
rteries. There were no complications from any percutane-
us procedure, although one thrombin-injected hepatic
rtery pseudoaneurysm required repeat intervention for
ersistent flow within 30 days.
In our series, the initial success rate of minimally inva-
ive intervention was 98%, with only 3% of patients requir-
ng repeat intervention within 30 days due to recurrent flow
r bleeding. Lagana et al reported a 5% occurrence of
eperfusion after endovascular treatment of splenic artery
neurysms. Recurrent bleeding was more likely to be ap-
arent within the first 30 days, as routine follow-up imag-
ng was not routinely performed within the initial 30 days
or asymptomatic aneurysms. In our series, all patients with
ecurrent aneurysm flow were treated successfully by a
econd endovascular or transabdominal procedure.
The timing of repeat imaging after initial intervention
arried widely between providers. Repeat imaging for hos-
ital inpatients was usually obtained within 96 hours. For
utpatient procedures, there was even more variability,
ith follow-up imaging frequently obtained several weeks
fter intervention. The timing to repeat imaging has to take
nto account the reason for intervention (bleeding vs en-
argement) and the severity of patient illness. Aneurysms
ausing bleeding leading to hemodynamic instability
hould be reimaged sooner than nonbleeding aneurysms
oiled due to size concerns. Although these aneurysms may
ppear to have been completely embolized or excluded at
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repeat imaging. This underscores the importance for repeat
imaging even when the initial procedure is felt to be suc-
cessful. The exact cause of recurrent flow within aneurysms
is not well characterized. The shifting of covered stents or
recanalization of collateral vessels has been re-
ported.11,17,18
The mean follow-up in our series of patients not lost
within the first 30 days was 524 days and was augmented by
a long-term follow-up survey. The length of follow-up
gives us confidence that we captured the vast majority of
recurrences or complications from treatment, although we
cannot completely exclude the possibility of unreported
complications, recurrences, or even deaths, given that not
all patients were able to be reached. Guillon et al noted no
instances of mid- or long-term recurrence in their series.11
Four patients reported recurrence of their splenic artery
aneurysms, although records at our institution for three of
them call into question their assertions or understanding of
the survey questions.
Two patients had long-term complications related to
aneurysm treatment. One patient developed sepsis after
splenic infarction, believed to have resulted from coil em-
bolization of a splenic artery aneurysm 50 days earlier.
Another patient developed a bile duct stricture 22 months
after coil embolization of a gastroduodenal artery aneurysm
that eventually necessitated hepaticojejunostomy 45 months
after aneurysm treatment.
CONCLUSIONS
This series represents the largest and most diverse series
of visceral artery aneurysms and pseudoaneurysms treated
by minimally invasive techniques with long-term follow-
up. The wide variety of endovascular and percutaneous
techniques employed and the willingness to combine these
techniques afforded a very high success rate with low recur-
rence and morbidity. As technology grows and the experi-
ence with these and emerging techniques increases, even
more VAAs will become amenable to minimally invasive
treatment.
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